Retail Clinics, The Emerging Market for Convenience and In-Store Healthcare

    Published: October 1, 2007 | Price: $995.00 – $5,990.00

    Retail clinics, also known as convenience clinics, represent a disruptive innovation into the U.S. health care market, which evolved from and is uniquely positioned to benefit from the health care system’s shortcomings. These clinics present a new opportunity for retail outlets to earn more revenue from rents and 'indirect' revenues from sales to the retail store as a result of a clinic visit. But there is also an opportunity for diagnostic and pharmaceutical companies to capitalize on this trend. Kalorama...
    Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey

    Published: March 22, 2013 | Price: $995.00 – $1,995.00

    Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey - Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical services. Yet they provide an option for busy Americans seeking a convenient option for basic healthcare needs such as vaccinations or cold remedies. Kalorama Information has published several studies on retail clinics since 2007. Over the past few years, we have analyzed the economic performance of stores and...
    Retail Clinics: Customer Survey 2018

    Published: June 22, 2018 | Price: $800.00 – $1,600.00

    Are Consumers Visiting Retail Clinics?  What For?  How Satisfied are Retail Clinic Customers? These questions and many others are answered in this report from Kalorama Information. Kalorama has covered the market for clinics located within a retail health setting since 2007, and has recently concluded a web-based survey of 2000 U.S. adults, where hundreds of retail clinic users were interviewed.  This report provides the results of this survey.  Questions Asked Include: Have You Ever Visited A Retail Clinic? Gender Of...
    Return of the Rx to OTC Switch – Market Analysis and Product Management Strategies, The

    Published: April 1, 2008 | Price: $500.00 – $3,990.00

    Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life. Kalorama Information's The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies contians a complete overview of the US market for prescription drugs likely to switch in the...
    Reusable Medical Devices and Instruments

    Published: November 1, 2008 | Price: $995.00 – $6,995.00

    Reusable medical instruments and devices are products that are sterilized or cleaned for reuse. Advances in medical sciences and, in particular, minimally invasive surgical and diagnostic procedures, have stimulated the development of new and improved medical devices. This is due to developments in engineering and material sciences. The design for reusability is important in an effort to provide cost effective healthcare. This Kalorama Information Report, Reusable Medical Devices and Instruments contains the following information:   Market Size and Forecast for...
    RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies

    Published: March 1, 2008 | Price: $995.00 – $3,990.00

    Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector. Full coverage of the market for RFID technologies in pharmaceutical manufacturing operations is provided, including.   Explanation of RFID Technologies Cost Savings from Implementation Total Market for RFID Technologies in Pharma Manufacturing Market Forecasts Major Companies Involved in RFID and...
    RFID Opportunities in Healthcare in the U.S.

    Published: June 1, 2007 | Price: $1,995.00 – $7,990.00

    RFID (Radio Frequency IDentification) technologies are dramatically changing many industries, but as detailed in Kalorama's market research report RFID Opportunities in Healthcare in the U.S., the greatest market for RFID is in healthcare. Hospitals, pharmaceutical companies, nursing homes, and other healthcare entities will benefit from using the technologies to keep track of inventories and patients. What are the best markets within healthcare for RFID? How will benefits outweigh costs? How are these technologies best implemented? Who are the leading providers...
    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    Published: November 1, 2003 | Price: $2,246.00 – $4,492.00

    Rheumatoid arthritis is a progressive disease of the joint structure that may be localized or systemic. It varies significantly in severity, producing symptoms that range from minor aches to severe disability and joint deformity. While rheumatoid arthritis can be diagnosed at any age, for childhood to the later years, it most commonly presents with significant symptoms at about middle age. From that point, the disease can progress quickly, slowly or virtually not at all. With an aging population, the unmet...
    Roche Diagnostics: Company Profile

    Published: January 21, 2015 | Price: $500.00 – $1,000.00

    Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Roche Diagnostics. Roche is the world's largest supplier of clinical diagnostics products, the world leader in IVD and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic...
    Roche Diagnostics: Company Profile

    Published: November 2, 2015 | Price: $250.00 – $500.00

    Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...
    Rx to OTC Switches 2009

    Published: May 1, 2009 | Price: $995.00 – $7,000.00

    While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of this decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's...
    Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs)

    Published: January 1, 2011 | Price: $150.00 – $300.00

    Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...
    Schizophrenia Therapeutics: A Market Briefing

    Published: April 1, 2005 | Price: $995.00 – $1,990.00

    Schizophrenia is a life long affliction. There is no permanent cure for this illness. However, numerous drugs have made the effective management of the disease a reality. This briefing examines both corrent and emerging therapeutic approaches for the management of schizophrenia. It provides an analysis of the current and future markets for these agents, including forecasts to 2009 segmented by geographic region and by type of drug and likely market scenarios for new agents not yet available. The briefing discusses...
    Selected Global Cytology Procedure Volumes

    Published: October 17, 2018 | Price: $1,000.00 – $2,000.00

    Presents Kalorama’s estimates of histology and cytology procedures, 2016-2021.
    Selected New Products in IVD

    Published: October 19, 2017 | Price: $200.00 – $400.00

    New products in IVD, as launched at major diagnostic conventions.